Literature DB >> 848682

Considerations that lower pancreatoduodenectomy mortality.

J W Braasch, B N Gray.   

Abstract

To aid in case selection for pancreatoduodencetomy and to gain information on the technical management of this operation and its complications, records of 279 patients who were treated for neoplasm or pancreatitis by this procedure between the years 1957 and 1975 were reviewed. The overall operative mortality was 12.5 per cent and was 10.7 per cent for the years 1969 throught 1974. The use of vagotomy did not prevent postoperative bleeding from the stomach, and the use of a stent did not make a statistically significant difference in morbidity or mortality. Postoperative hemorrhage is an ominous complication and is best treated conservatively until blood loss cannot be replaced. Preoperative serum bilirubin levels above 20 mg/100 ml indicate a two-stage operative procedure as does the presence of right upper quadrant sepsis. The resection of malignant disease of the duodenum and lower bile duct is followed by a high mortality and requires total pancreatectomy if a satisfactory pancreatojejunostomy cannot be constructed.

Entities:  

Mesh:

Year:  1977        PMID: 848682     DOI: 10.1016/0002-9610(77)90135-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  35 in total

1.  Evaluation of surgical risk in palliation and resection of pancreatic cancer. Perspective study and tables to calculate the risk.

Authors:  S Pedrazzoli; B Bonadimani; C Sperti; C Pasquali; F Cappellazzo; S Catalini; A Piccoli; C Militello
Journal:  Int J Pancreatol       Date:  1992-12

Review 2.  Pylorus-preserving pancreatoduodenectomy--technical aspects.

Authors:  J W Braasch; M Gagner
Journal:  Langenbecks Arch Chir       Date:  1991

3.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

4.  Survival in 1001 patients with carcinoma of the pancreas.

Authors:  M M Connolly; P J Dawson; F Michelassi; A R Moossa; F Lowenstein
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

5.  Hemorrhage after pancreatoduodenectomy.

Authors:  B Rumstadt; M Schwab; P Korth; M Samman; M Trede
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

6.  [Reconstructive operation following duodenopancreatectomy].

Authors:  A Fritsch
Journal:  Langenbecks Arch Chir       Date:  1985

7.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

8.  Serum blood urea nitrogen and serum albumin on the first postoperative day predict pancreatic fistula and major complications after pancreaticoduodenectomy.

Authors:  Daniel M Relles; Nathan G Richards; Jordan P Bloom; Eugene P Kennedy; Patricia K Sauter; Benjamin E Leiby; Ernest L Rosato; Charles J Yeo; Adam C Berger
Journal:  J Gastrointest Surg       Date:  2012-12-06       Impact factor: 3.452

9.  Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments.

Authors:  R M Beazley; N Hadjis; I S Benjamin; L H Blumgart
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

10.  Pancreaticoduodenal resection. Surgical experience and evaluation of risk factors in 103 patients.

Authors:  J P Lerut; P R Gianello; J B Otte; P J Kestens
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.